Nine Biopharm
PrivateLast Round
Series A
Dec 20, 2021
Total Funding Raised
$6.75M
Company Overview
Nine Biopharm is a biomaterials company that develops peptide-based materials for pharmaceuticals, medical devices, and cosmetics using a proprietary computer simulation platform.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Fashion & Beauty
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nine Biopharm Comps
Public and private peers based on sector, stage, and business model.
Nine Biopharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 20, 2021 |
Nine Biopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capstone Partners | Series A |
| Korea Asset Investment Securities | Series A |
| Laplace Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 20, 2021
$7M round led by Korea Asset Investment Securities.
Nine Biopharm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nine Biopharm's valuation, stock price, and market status.
